Literature DB >> 12434719

Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center.

Audrey J Lee1, Maureen S Boro, Katherine K Knapp, Joy L Meier, Nancy E Korman.   

Abstract

Pharmacist recommendations and their clinical and economic outcomes in a Veterans Affairs (VA) medical center were studied. The first 600 pharmacist recommendations that met study criteria were evaluated for type and frequency, rate of acceptance by physicians, potential benefit or harm, and economic consequences. The study site included inpatient and outpatient settings and a skilled-nursing facility. The most frequent types of pharmacist recommendations involved adjusting the dosage or frequency of administration and discontinuing a drug that was not indicated for the patient's medical problem. The rate of acceptance of the recommendations was 92%. The recommendations led to improved clinical outcomes in over 30% of cases in each setting and no change in over 40% of cases in each setting. Evaluators determined that patient harm was avoided by the recommendations in 90% of cases; patient harm was caused in less than 1% of cases. The overall mean cost avoidance per recommendation was $700, and the mean total cost avoidance for all 600 recommendations was $420,155. Pharmacist recommendations improved clinical outcomes and saved money at a VA medical center.

Entities:  

Mesh:

Year:  2002        PMID: 12434719     DOI: 10.1093/ajhp/59.21.2070

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  24 in total

1.  The Daniel K. Inouye College of Pharmacy Scripts: Provider Status for Pharmacists: Why it Matters for Other Healthcare Providers.

Authors:  Christina L Mnatzaganian; Victoria Rupp; Carolyn Ma
Journal:  Hawaii J Med Public Health       Date:  2015-09

Review 2.  Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review.

Authors:  Thi-Ha Vo; Bruno Charpiat; Claire Catoire; Michel Juste; Renaud Roubille; François-Xavier Rose; Sébastien Chanoine; Jean-Luc Bosson; Ornella Conort; Benoît Allenet; Pierrick Bedouch
Journal:  Drug Saf       Date:  2016-02       Impact factor: 5.606

3.  Value of pharmacist medication interviews on optimizing the electronic medication reconciliation process.

Authors:  Audrey Lee; Arjun Varma; Maureen Boro; Nancy Korman
Journal:  Hosp Pharm       Date:  2014-06

Review 4.  Selecting a clinical intervention documentation system for an academic setting.

Authors:  Brent I Fox; Miranda Andrus; E Kelly Hester; Debbie C Byrd
Journal:  Am J Pharm Educ       Date:  2011-03-10       Impact factor: 2.047

5.  Implementation of a school-wide clinical intervention documentation system.

Authors:  T Lynn Stevenson; Brent I Fox; Miranda Andrus; Dana Carroll
Journal:  Am J Pharm Educ       Date:  2011-06-10       Impact factor: 2.047

6.  Analysis of cost avoidance from pharmacy students' clinical interventions at a psychiatric hospital.

Authors:  Austin R Campbell; Leigh Anne Nelson; Ellie Elliott; Robin Hieber; Roger W Sommi
Journal:  Am J Pharm Educ       Date:  2011-02-10       Impact factor: 2.047

7.  Hospital pharmacists' perceived beliefs and responsibilities in indication-based off-label prescribing.

Authors:  Ramsankar Basak; David J McCaffrey
Journal:  Int J Clin Pharm       Date:  2017-12-04

8.  The scope and value of an anticoagulation stewardship program at a community teaching hospital.

Authors:  Maura K Wychowski; Christina I Ruscio; Peter A Kouides; Ronald L Sham
Journal:  J Thromb Thrombolysis       Date:  2017-04       Impact factor: 2.300

9.  Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.

Authors:  Ji-Min Han; Young-Mi Ah; Sung Yun Suh; Sun-Hoi Jung; Hyeon Joo Hahn; Seock-Ah Im; Ju-Yeun Lee
Journal:  Int J Clin Pharm       Date:  2016-06-30

10.  Patient attitudes and experiences that predict medication discontinuation in the Veterans Health Administration.

Authors:  Amy Linsky; Steven R Simon; Kelly Stolzmann; Mark Meterko
Journal:  J Am Pharm Assoc (2003)       Date:  2017-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.